Objective: Emotion-regulating coping is associated with improvements in psychological and physical health outcomes. Yet in the context of prostate cancer-related stressors, limited research has characterized associations of emotion-regulating coping processes (emotional expression, emotional processing) and inflammatory processes that are related to disease risk. This investigation examined the relation of Emotional Approach Coping (EAC) with markers of inflammation to test the hypothesis that higher EAC scores at study entry (T1) would be associated with lower proinflammatory markers four months later (T2), specifically sTNF-RII, CRP, and IL-6. Methods: Forty-one men (M age = 66.62 years; SD = 9.62) who had undergone radical prostatectomy or radiation therapy for localized prostate cancer within two years completed questionnaires, including assessments of EAC, at T1, and provided blood samples for immune assessments at T2. Results: When controlling for relevant biobehavioral controls, emotional processing predicted lower IL-6 (B = À.66, p < .01), sTNF-RII (B = À.43, p < .05), and CRP (B = À.43, p < .10), whereas emotional expression was significantly associated with higher levels of sTNF-RII (B = .55, p < .05). Associations of emotional expression and IL-6 (B = .38, p < .10), and CRP (B = .44, p < .10) approached significance. Probing interactions of emotional processing and expression (though only approaching significance) suggested that expression of emotion is associated with higher inflammation (CRP and sTNF-RII) only in the context of low emotional processing. Conclusions: Attempts at emotion regulation via emotional processing appear to modulate inflammatory processes. Understanding, making meaning of, and working through emotional experience may be a promising target of intervention to reduce inflammation with potential effects on psychological and cancer outcomes in men with prostate cancer.
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Introduction
The experience of cancer diagnosis and treatment exposes individuals to numerous physical and emotional stressors and accounts for increased risk of emotional distress and depression. The first one to two years following radical prostatectomy or completion of radiation treatment for prostate cancer are markedly demanding and characterized by relatively rapid changes in physical functioning (Litwin et al., 2001; Stanford et al., 2000) , increased risk for depression (Jayadevappa et al., 2011 ), sleep disturbance (Savard et al., 2005 , worry and anxiety (Sharpley et al., 2008) , and declining health-related quality of life (Gore et al., 2009) . Emotional perturbations and chronic negative affective states associated with stressors can invoke potent negative effects on inflammatory and other cellular immune processes (Irwin, 2002; Kemeny, 2007; Reiche et al., 2004; Segerstrom and Miller, 2004; Steptoe et al., 2007) , which can compound the burden associated with cancer and have a direct and indirect impact on mental and physical health outcomes (Grivennikov et al., 2010; Mantovani et al., 2008 ; see also Irwin and Cole, 2011 on behavior and inflammation). Coping through avoidance has typically been associated
